|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowances for credit losses of $41 and $173, respectively | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Assets held for sale - current | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Assets held for sale - non-current | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES and SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Loan payable - current | ||||||||||||||||||||
| Financing payable | ||||||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||||||
| Liabilities held for sale - current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Loan payable - non-current | ||||||||||||||||||||
| Operating lease liabilities - non-current | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Warrant liability and other long-term liabilities (Note 10) | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Liabilities held for sale - non-current | ||||||||||||||||||||
| Warrant liability (Note 10) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock, no par value, 100,000 shares authorized; 9,771 shares issued and 9,081 shares outstanding as of December 31, 2024; 9,764 shares issued and 9,703 shares outstanding as of September 30, 2024 | ||||||||||||||||||||
| Treasury stock at cost; 6,906 shares as of June 30, 2022 and September 30, 2021 | ||||||||||||||||||||
| Treasury stock at cost; 691 shares as of December 31, 2024 and September 30, 2024 | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Common stock, no par value (in dollars per share) | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Treasury stock, shares held (in shares) | ||||||||||||||||||||
Loading...
